These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6169582)

  • 21. [Plasma level studies of quinidine retard, their significance for dosage and onset of effect].
    Guckenbiehl W; Just H; Olbermann M; Lang KF
    Med Klin; 1976 Apr; 71(14):586-92. PubMed ID: 57566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dynamic electrocardiography evaluation of the effectiveness of prajmalium bitartrate, disopyramide and procainamide in patients with stabilized ventricular extrasystole].
    Naccarella F; Del Corso P; Palmieri M; Cantelli I; Lentini G; Bracchetti D
    G Ital Cardiol; 1981; 11(3):338-44. PubMed ID: 6169577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-arrhythmic effectiveness of neogilurhythmal in extrasystolic arrhythmia].
    Kobuliia BG; Maĭsuradze MZ; Mindadze KA; Imnadze GN; Saatashvili GA
    Kardiologiia; 1992 Jun; 32(6):38-9. PubMed ID: 1383594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Holter analysis of ventricular arrhythmias and its treatment with propafenone].
    Peralta Heredia R
    Arch Inst Cardiol Mex; 1986; 56(3):225-30. PubMed ID: 2428317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine.
    Shapiro W; Park J; Koch GG
    Am J Cardiol; 1982 Feb; 49(2):445-54. PubMed ID: 6174041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical investigation with Holter's monitoring of the antiarrhythmic effect of adonisidum.
    Chen SX; Zhang SH; Zhang XZ; Zheng XJ; Yu G; Huang MX; Zheng DS
    J Tradit Chin Med; 1989 Mar; 9(1):35-9. PubMed ID: 2474726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison between amiodarone and disopyramide in the treatment of ventricular extrasystoles].
    Gaudeau B; Badouraly A; Herpin D; Tournadre P; Boutaud P; Amiel A; Guillem JP; Demange J
    Ann Cardiol Angeiol (Paris); 1986 Jan; 35(1):43-8. PubMed ID: 2421631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of sustained-release quinidines given twice daily to patients with ventricular ectopy.
    Lehmann CR; Boran KJ; Kruyer WB; Van Reet RE; Scoville GS; Pierson WP; Melikian AP; Crowe JT; Wright GJ
    J Clin Pharmacol; 1986; 26(8):598-604. PubMed ID: 3793950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cordichin in the treatment of ventricular extrasystole and tachycardial rhythm disorders].
    Jancke T
    ZFA (Stuttgart); 1982 Mar; 58(8):488-92. PubMed ID: 6176082
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effectiveness and characteristics of the action of etmozin in treating extrasystole in middle-aged and elderly patients].
    Korkushko OV; Butenko AG; Kaukenas IK
    Ter Arkh; 1986; 58(6):65-70. PubMed ID: 2429380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study of the antiarrhythmic action of Mexityl in ventricular disorders of the cardiac rhythm].
    Mazur NA; Liakishev AA; Podrid FD; Piotrovskiĭ VK
    Kardiologiia; 1979 Oct; 19(10):17-21. PubMed ID: 91699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of the effectiveness and stability of action of sustained-release disopyramide phosphate by the Holter method].
    de Lombera Romero F; Martínez-Osorio Corzan L; Seoane J; Franco JR
    Rev Esp Cardiol; 1985; 38(6):446-50. PubMed ID: 2419948
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anti-arrhythmia effect of prolecophen in patients with extrasystole in comparison with other anti-arrhythmia drugs].
    Abdalla A; Mazur NA; Sumarokov AB
    Kardiologiia; 1989 Oct; 29(10):97-9. PubMed ID: 2482381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of ethacizin in ventricular arrhythmias refractory to prior anti-arrhythmia drug therapy].
    Shugushev KhKh
    Kardiologiia; 1986 Jun; 26(6):43-7. PubMed ID: 2429007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias?
    Kim SG; Seiden SW; Felder SD; Waspe LE; Fisher JD
    N Engl J Med; 1986 Aug; 315(6):356-62. PubMed ID: 2426592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
    Ferrara E; Vitali A; Cucchi GF
    Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
    Wagner WL; Manz M; Lüderitz B
    Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 40. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.